Schiller India co-hosted an innovative workshop on the Robotic Thermocoagulative Hemispherotomy (ROTCH) a technique by using ROSA Brain installed at the All India Institute of Medical Sciences (AIIMS), Delhi : developed by Dr. Sarat Chandra, a prominent neurosurgeon at AIIMS, New Delhi.
Dr. Sarat Chandra’s innovative ROTCH procedure represents a significant leap forward in the treatment of drug-resistant epilepsy caused by hemispheric pathology. Unlike traditional surgical methods, ROTCH is a minimally invasive, “bloodless” technique that utilizes advanced robotic systems to perform precise thermocoagulation. This method employs radiofrequency energy to disconnect pathological brain tissue, thereby reducing the need for extensive craniotomies and minimizing surgical morbidity.
In a remarkable show of international collaboration, top neurosurgeons from Tel Aviv Medical University in Israel have partnered with AIIMS to learn these groundbreaking techniques. Prof. Jonathan Roth, Chairman of Neurosurgery, and Prof. Ida Strauss, Head of Functional Neurosurgery at Tel Aviv Medical University, are visiting AIIMS, Delhi to study the ROTCH technique and explore future research collaborations.
Dr. Sarat Chandra’s contributions to neurosurgery extend beyond the ROTCH technique. His pioneering work includes the development of other innovative techniques such as endoscopic Hemispherotomy, endoscopic corpus callosotomy, and robotic-guided radiofrequency thermocoagulation of hypothalamic hamartomas. These advancements have significantly broadened the scope and efficacy of minimally invasive epilepsy surgery, offering new hope to patients with challenging medical conditions.
Schiller India is proud to support such transformative medical advancements and remains dedicated to fostering education and collaboration within the medical community. By facilitating workshops like these, Schiller India aims to empower healthcare professionals with the knowledge and skills necessary to implement such critical surgical techniques, ultimately improving patient outcomes and advancing the field of neurosurgery.